Aristotle Atlantic Partners’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32M | Sell |
612,826
-23,997
| -4% | -$1.44M | 1.5% | 21 |
|
|
2025
Q4 | $37.5M | Sell |
636,823
-390,508
| -38% | -$23.7M | 1.71% | 15 |
|
|
2025
Q3 | $57.2M | Sell |
1,027,331
-24,946
| -2% | -$1.34M | 1.66% | 16 |
|
|
2025
Q2 | $54.1M | Buy |
1,052,277
+85,904
| +9% | +$4.32M | 1.65% | 15 |
|
|
2025
Q1 | $56.7M | Buy |
966,373
+212,011
| +28% | +$14.4M | 1.91% | 14 |
|
|
2024
Q4 | $54.3M | Sell |
754,362
-31,142
| -4% | -$2.29M | 1.71% | 16 |
|
|
2024
Q3 | $62.8M | Buy |
785,504
+63,835
| +9% | +$4.8M | 1.95% | 13 |
|
|
2024
Q2 | $51.7M | Sell |
721,669
-14,090
| -2% | -$1.04M | 1.68% | 16 |
|
|
2024
Q1 | $51.8M | Sell |
735,759
-23,655
| -3% | -$1.69M | 1.69% | 17 |
|
|
2023
Q4 | $58.6M | Buy |
759,414
+105,779
| +16% | +$6.97M | 2.06% | 14 |
|
|
2023
Q3 | $44.5M | Sell |
653,635
-8,579
| -1% | -$678K | 1.78% | 16 |
|
|
2023
Q2 | $54.1M | Buy |
662,214
+139,028
| +27% | +$11.2M | 2.04% | 12 |
|
|
2023
Q1 | $38.8M | Sell |
523,186
-17
| -0% | -$1.31K | 2% | 11 |
|
|
2022
Q4 | $43.4M | Buy |
523,203
+6,863
| +1% | +$545K | 2.43% | 12 |
|
|
2022
Q3 | $36.7M | Buy |
516,340
+143,272
| +38% | +$12.4M | 2.23% | 11 |
|
|
2022
Q2 | $32.3M | Sell |
373,068
-15,032
| -4% | -$1.41M | 2.49% | 9 |
|
|
2022
Q1 | $42M | Buy |
388,100
+5,712
| +1% | +$589K | 2.6% | 9 |
|
|
2021
Q4 | $49.5M | Buy |
382,388
+17,780
| +5% | +$2.18M | 2.87% | 8 |
|
|
2021
Q3 | $44.2M | Buy |
364,608
+4,200
| +1% | +$511K | 2.92% | 8 |
|
|
2021
Q2 | $40.6M | Buy |
360,408
+4,380
| +1% | +$461K | 2.68% | 9 |
|
|
2021
Q1 | $34M | Buy |
356,028
+8,056
| +2% | +$735K | 2.49% | 10 |
|
|
2020
Q4 | $27.6M | Sell |
347,972
-18,676
| -5% | -$1.35M | 2.13% | 16 |
|
|
2020
Q3 | $22.7M | Buy |
366,648
+4,152
| +1% | +$270K | 2% | 21 |
|
|
2020
Q2 | $23.9M | Buy |
362,496
+62,400
| +21% | +$3.74M | 2.3% | 13 |
|
|
2020
Q1 | $14.2M | Sell |
300,096
-41,948
| -12% | -$2.1M | 2.17% | 16 |
|
|
2019
Q4 | $18.8M | Buy |
342,044
+210,136
| +159% | +$11M | 2.4% | 15 |
|
|
2019
Q3 | $6.45M | Buy |
131,908
+4,180
| +3% | +$210K | 1.86% | 12 |
|
|
2019
Q2 | $6.66M | Buy |
127,728
+5,700
| +5% | +$287K | 1.94% | 12 |
|
|
2019
Q1 | $6.06M | Buy |
122,028
+5,320
| +5% | +$239K | 1.84% | 12 |
|
|
2018
Q4 | $4.22M | Buy |
116,708
+32,588
| +39% | +$1.36M | 1.49% | 15 |
|
|
2018
Q3 | $4.12M | Sell |
84,120
-24,320
| -22% | -$1.08M | 2.52% | 15 |
|
|
2018
Q2 | $4.01M | Buy |
108,440
+68,440
| +171% | +$2.61M | 1.39% | 16 |
|
|
2018
Q1 | $1.51M | Buy |
+40,000
| New | +$1.41M | 0.55% | 32 |
|
Other funds holding TECH
VCM
VPM
MC
Aristotle Atlantic Partners's TECH Position: Q1 2026 in Review
Aristotle Atlantic Partners reduced its Bio-Techne (TECH) stake by 3.8% in Q1 2026, selling an estimated $1.44M and leaving 612,826 shares worth $32M. The position accounts for 1.5% of the portfolio, ranked #21.
Aristotle Atlantic Partners first reported a position in TECH in Q1 2018 and has held it in 33 quarters since. The position peaked at $62.8M in Q3 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Aristotle Atlantic Partners held 612,826 shares of Bio-Techne worth $32M as of Q1 2026.
- Aristotle Atlantic Partners sold 23,997 Bio-Techne shares in Q1 2026, an estimated $1.44M.
- Bio-Techne made up 1.5% of Aristotle Atlantic Partners's portfolio in Q1 2026, its #21 holding.
- Aristotle Atlantic Partners first reported a position in Bio-Techne in Q1 2018 and has held it in 33 quarters since.
- Aristotle Atlantic Partners's Bio-Techne position peaked at $62.8M in Q3 2024.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Aristotle Atlantic Partners's 13F filing for Q1 2026, filed 15 May 2026.